Clinical Trials Logo

Filter by:
NCT ID: NCT02656082 Completed - Clinical trials for Lupus Erythematosus, Cutaneous

Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

TARGET-DLE
Start date: February 1, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Etanercept which is given through intradermal injection is effective in the treatment of discoid lupus erythematosus (DLE). The investigators also would like to develop new tests to measure skin inflammation by scanning the affected skin using optical coherence tomography (OCT), thermography and laser doppler imaging (LDI) and taking photographs of the rash (to be done before and after treatment). If the findings from these new tests are similar to the ones from taking a sample of skin (biopsy), then the latter (which is an invasive test) can be avoided.

NCT ID: NCT02655952 Completed - Clinical trials for Metastatic Breast Cancer

Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients

Start date: April 2016
Phase: Phase 1
Study type: Interventional

The Wnt proteins belong to a family of proteins that have been demonstrated to play a role in the formation and dissemination of tumours. The present project focuses on the critical role of the Wnt-5a protein in the pathobiological processes that lead to metastatic cancer disease. WntResearch has identified a formylated 6 amino acid peptide fragment, named Foxy-5, which mimick the effects of Wnt-5a to impair migration of epithelial cancer cells and thereby acting anti-metastatic. The aim of the first clinical phase I study was to establish the recommended dose for a clinical phase II study and enable further development of Foxy-5 as a first in class anti-metastatic cancer drug. The study did not see any DLTs and therefore failed to reach maximum tolerated dose (MTD); no recommended phase II dose (RP2D) could therefore be established based on toxicity. The aim of this study is to continue to establish the safety profile of Foxy-5 in higher doses, and determine the RP2D for later stage development based on any observed DLT's/MTD and further analysis of the pharmacodynamic profile of Foxy-5 to determine the biological response dose (BRD).

NCT ID: NCT02655926 Completed - Clinical trials for Obsessive-Compulsive Disorder

Deep Brain Stimulation for Severe Obsessive Compulsive Disorder

Start date: September 2012
Phase: N/A
Study type: Interventional

The overarching aim is to compare the effects of ventral capsule/ventral striatum (VC/VS) and subthalamic nucleus (STN) deep brain stimulation (DBS) in the same participants. Investigators will test the hypothesis, grounded in cognitive neuroscience, that DBS at both sites is better than either site alone for treating the symptom dimensions of obsessive compulsive disorder (OCD). Specifically, Investigators will employ novel cognitive paradigms and neurophysiological measures of cortical synaptic function to test the hypothesis that VS/VC and STN DBS have different mechanisms of action and that alleviation of OCD symptoms is mediated by improvement in mood/anxiety with VS/VC DBS and by directly interrupting obsessions and compulsions with STN DBS. Investigators will additionally determine whether adjunctive cognitive behavioural therapy (CBT) enhances the response to DBS by providing the cognitive and behavioural skills to optimise symptom management and daily function.

NCT ID: NCT02655887 Completed - Clinical trials for Peripheral Vascular Disease

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease

VERNACULAR
Start date: June 15, 2016
Phase: N/A
Study type: Interventional

The BARD® Venovo™ Venous Stent Study is a non-randomized clinical study intended to collect confirmatory evidence of the safety and effectiveness of the Venous Stent for the treatment of iliofemoral occlusive disease.

NCT ID: NCT02655809 Completed - Clinical trials for Total Knee Replacement

Physica KR Fluoroscopy Study

Start date: June 2015
Phase: N/A
Study type: Interventional

The aim of this study is to assess the in vivo kinematics and range of motion of a single-surgeon clinical series of TKA performed with a fixed-bearing cruciate retaining total knee arthroplasty that has a roll-back mechanism and compare it with the kinematic of the normal healthy knee. Patients would be evaluated by fluoroscopic examination during weight bearing activities (lounging, kneeling and stairs climbing).

NCT ID: NCT02655406 Completed - Varicose Veins Clinical Trials

COmpressioN Following Endovenous TreatmenT of Incompetent Varicose Veins

CONFETTI
Start date: January 2016
Phase: N/A
Study type: Interventional

This study will be looking at the effect of compression therapy in patients having endovenous treatment for varicose veins using foam sclerotherapy. Patients will be randomised to either the compression group (group A) or the no compression group (group B). The pain scores, compliance, quality of life scores, occlusion rate at 6 months as well as the cost effectiveness of each intervention will be assessed.

NCT ID: NCT02655367 Completed - Metabolic Syndrome Clinical Trials

The Effect of Oat Processing on Gastric Emptying and Satiety Induced After Consuming Porridge

Oatmet
Start date: November 2015
Phase: N/A
Study type: Interventional

This crossover study is designed to compare the gastric layering and rates of emptying and by inference rates of digestion of two different porridge meals prepared from either finely milled or flaked oats. On each of two study days, a total of 9 MRI scans will be taken, I baseline and 8 post meal, to assess gastric layering and emptying over three hours. Blood samples will also be taken periodically over the same period in order to determine changes in concentrations of circulating glucose, insulin and key gastrointestinal hormones. Participants will also be asked to complete a questionnaire at predetermined times to assess feelings of satiation.

NCT ID: NCT02655315 Completed - Parkinson Disease Clinical Trials

Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease

FAIRPARKII
Start date: February 9, 2016
Phase: Phase 2
Study type: Interventional

This study evaluates the effect of iron chelation as a therapeutic strategy to slow the progression of Parkinson's disease. Half of participants will receive the deferiprone to 15 mg / kg twice daily morning and evening (30mg / kg per day), while the other half will receive a placebo. The treatment lasts nine months.

NCT ID: NCT02654548 Completed - Clinical trials for Polycystic Ovary Syndrome

Sebum Excretion in Neonates of Women With Polycystic Ovary Syndrome (PCOS)

Start date: June 2013
Phase: N/A
Study type: Interventional

To investigate whether women with polycystic ovary syndrome who are post-partum excrete higher levels of sebum in comparison to healthy controls due to high levels of androgens.

NCT ID: NCT02654470 Completed - Clinical trials for Non-valvular Atrial Fibrillation

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

Start date: July 16, 2019
Phase:
Study type: Observational

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study